Meeting of the Advisory Committee on Blood and Tissue Safety and Availability, 67012 [2012-27307]

Download as PDF 67012 Federal Register / Vol. 77, No. 217 / Thursday, November 8, 2012 / Notices the Board recognized that correspondent bank balance sheets and ROE are typically driven largely by services that are not similar to those provided by the Reserve Banks. Because the contractual clearing balance program has been eliminated and correspondent banks are not the primary competitors of the Reserve Banks’ priced services, correspondent banks no longer serve as the best PSAF benchmark peer group. User-owned utilities are increasingly becoming the Reserve Banks’ key priced services competitors; however, because no reliable comparative data are publicly available for the user-owned utilities, it also does not provide a viable model for the PSAF. Lacking a more specific viable peer group, the Board believes modeling the PSAF on a PTF model is appropriate. The Board believes that such a change in the PSAF methodology does not have a direct and material adverse effect on the ability of other service providers to compete effectively with Reserve Banks in providing similar services. Rather, the Board believes that this PSAF revision will facilitate competition between the Reserve Banks and private-sector providers. V. Paperwork Reduction Act In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. ch. 3506; 5 CFR part 1320 appendix A.1), the Board has reviewed the proposal under the authority delegated to the Board by the Office of Management and Budget. The proposal contains no provisions subject to the Paperwork Reduction Act. By order of the Board of Governors of the Federal Reserve System, October 25, 2012. Robert deV. Frierson, Secretary of the Board. [FR Doc. 2012–26918 Filed 11–7–12; 8:45 am] BILLING CODE 6210–01–P The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than December 3, 2012. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. Townsend Holding Company, Grove, Oklahoma; to become a bank holding company by acquiring 100 percent of the voting shares of Bank of Grove, Grove, Oklahoma. Board of Governors of the Federal Reserve System, November 5, 2012. Robert deV. Frierson, Secretary of the Board. [FR Doc. 2012–27313 Filed 11–7–12; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Advisory Committee on Blood and Tissue Safety and Availability Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice. AGENCY: FEDERAL RESERVE SYSTEM tkelley on DSK3SPTVN1PROD with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. VerDate Mar<15>2010 18:34 Nov 07, 2012 Jkt 229001 As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) will hold a meeting. The meeting will be open to the public. SUMMARY: National Institutes of Health Conference Room, 5635 Fisher Lane, Terrace Level, Rockville, MD 20852. ADDRESSES: Mr. James Berger, Senior Advisor for Blood Policy and Executive Secretary ACBTSA, Division of Blood and Tissue Safety and Availability, Office of HIV/ AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, 1101 Wootton Parkway, Suite 250, Rockville, MD 20852, (240) 453–8809, Fax (240) 453– 8456, email ACBSA@hhs.gov. FOR FURTHER INFORMATION CONTACT: The ACBTSA shall provide advice to the Secretary through the Assistant Secretary for Health. The Committee shall advise on a range of policy issues to include: innovations in blood and tissue products and their potential impact on emergency preparedness. The public will have the opportunity to present their views to the Committee during a public comment session scheduled for December 7, 2012. Comments will be limited to five minutes per speaker and must be pertinent to the discussion. Preregistration is required for participation in the public comment session. Any member of the public who would like to participate in this session is encouraged to contact the Executive Secretary to register for time (limited to 5 minutes); individuals must register prior to close of business on December 3, 2012. If it is not possible to provide 30 copies of the material to be distributed, then individuals are requested to provide a minimum of one (1) copy of the document(s) to be distributed prior to the close of business on December 5, 2012. It is also requested that any member of the public who wishes to provide comments to the Committee utilizing electronic data projection submit the necessary material to the Executive Secretary prior to the close of business on December 3, 2012. SUPPLEMENTARY INFORMATION: Dated: November 2, 2012. James J. Berger, Senior Advisor for Blood Policy, Executive Secretary ACBTSA. [FR Doc. 2012–27307 Filed 11–7–12; 8:45 am] BILLING CODE 4150–41–P The meeting will take place Thursday, December 6, and Friday, December 7, 2012, from 8:00 a.m. to 4:00 p.m. on both days. DATES: PO 00000 Frm 00062 Fmt 4703 Sfmt 9990 E:\FR\FM\08NON1.SGM 08NON1

Agencies

[Federal Register Volume 77, Number 217 (Thursday, November 8, 2012)]
[Notices]
[Page 67012]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-27307]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


 Meeting of the Advisory Committee on Blood and Tissue Safety and 
Availability

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Advisory Committee on Blood and Tissue Safety and Availability 
(ACBTSA) will hold a meeting.
    The meeting will be open to the public.

DATES: The meeting will take place Thursday, December 6, and Friday, 
December 7, 2012, from 8:00 a.m. to 4:00 p.m. on both days.

ADDRESSES: National Institutes of Health Conference Room, 5635 Fisher 
Lane, Terrace Level, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Mr. James Berger, Senior Advisor for 
Blood Policy and Executive Secretary ACBTSA, Division of Blood and 
Tissue Safety and Availability, Office of HIV/AIDS and Infectious 
Disease Policy, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, 1101 Wootton Parkway, Suite 
250, Rockville, MD 20852, (240) 453-8809, Fax (240) 453-8456, email 
ACBSA@hhs.gov.

SUPPLEMENTARY INFORMATION: The ACBTSA shall provide advice to the 
Secretary through the Assistant Secretary for Health. The Committee 
shall advise on a range of policy issues to include: innovations in 
blood and tissue products and their potential impact on emergency 
preparedness.
    The public will have the opportunity to present their views to the 
Committee during a public comment session scheduled for December 7, 
2012. Comments will be limited to five minutes per speaker and must be 
pertinent to the discussion. Pre-registration is required for 
participation in the public comment session. Any member of the public 
who would like to participate in this session is encouraged to contact 
the Executive Secretary to register for time (limited to 5 minutes); 
individuals must register prior to close of business on December 3, 
2012. If it is not possible to provide 30 copies of the material to be 
distributed, then individuals are requested to provide a minimum of one 
(1) copy of the document(s) to be distributed prior to the close of 
business on December 5, 2012. It is also requested that any member of 
the public who wishes to provide comments to the Committee utilizing 
electronic data projection submit the necessary material to the 
Executive Secretary prior to the close of business on December 3, 2012.

    Dated: November 2, 2012.
James J. Berger,
Senior Advisor for Blood Policy, Executive Secretary ACBTSA.
[FR Doc. 2012-27307 Filed 11-7-12; 8:45 am]
BILLING CODE 4150-41-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.